Randomised, Double Blind, Controlled, Safety, Tolerability and Immunogenicity Phase II Trial of Chimerivax(TM)-Je and Japanese Encephalitis Inactivated Mouse Brain Vaccine in Children of Descending Age.

Trial Profile

Randomised, Double Blind, Controlled, Safety, Tolerability and Immunogenicity Phase II Trial of Chimerivax(TM)-Je and Japanese Encephalitis Inactivated Mouse Brain Vaccine in Children of Descending Age.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2012

At a glance

  • Drugs Japanese encephalitis vaccine; Measles virus vaccine live
  • Indications Japanese encephalitis; Measles
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 02 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Mar 2010 Planned end date changed from 1 Dec 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
    • 18 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top